Spleen tyrosine kinase mediates high glucose-induced transforming growth factor-Β1 up-regulation in proximal tubular epithelial cells

Experimental Cell Research

Volumn 318, Issue 15, 2012, Pages 1867-1876

  Yang, Won Seok ^a   Chang, Jai Won ^a   Han, Nam Jeong ^b   Lee, Sang Koo ^a   Park, Su Kil ^a  

^a University of Ulsan College of Medicine   (South Korea)

^b Asan Institute for Life Sciences   (South Korea)

Author keywords

Activator protein 1; High glucose; Nuclear factor B; P21 activated kinase 2; Spleen tyrosine kinase; Transforming growth factor 1

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; DNA; GLUCOSE; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; P21 ACTIVATED KINASE 2; PROTEIN KINASE SYK; PROTEIN KINASE SYK INHIBITOR; PROTEIN KINASE SYK INHIBITOR 574711; SERINE; SMALL INTERFERING RNA; SYNAPTOTAGMIN I; TRANSCRIPTION FACTOR AP 1; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG;

ARTICLE; DIABETIC NEPHROPATHY; DNA BINDING; ENZYME ACTIVATION; ENZYME INHIBITION; GENE EXPRESSION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; KIDNEY CELL; KIDNEY PROXIMAL TUBULE; KIDNEY PROXIMAL TUBULE CELL; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; UPREGULATION;

EID: 84863785125     PISSN: 00144827     EISSN: 10902422     Source Type: Journal    
DOI: 10.1016/j.yexcr.2012.05.016     Document Type: Article

References (35)

1. Sada K., Takano T., Yanagi S., Yamamura H. Structure and function of Syk protein-tyrosine kinase. J. Biochem. 2001, 130:177-186.
2. Masuda E.S., Schmitz J. Syk inhibitors as treatment for allergic rhinitis. Pulm. Pharmacol. Ther. 2008, 21:461-467.
3. Weinblatt M.E., Kavanaugh A., Burgos-Vargas R., Dikranian A.H., Medrano-Ramirez G., Morales-Torres J.L., Murphy F.T., Musser T.K., Straniero N., Vicente-Gonzales A.V., Grossbard E. Treatment of rheumatoid arthritis with a Syk kinase inhibitor: a twelve-week, randomized, placebo-controlled trial. Arthritis Rheum. 2008, 58:3309-3318.
4. Bahjat F.R., Pine P.R., Reitsma A., Cassafer G., Baluom M., Grillo S., Chang B., Zhao F.F., Payan D.G., Grossbard E.B., Daikh D.I. An orally bioavailable spleen tyrosine kinase inhibitor delays disease progression and prolongs survival in murine lupus. Arthritis Rheum. 2008, 58:1433-1444.
5. Podolanczuk A., Lazarus A.H., Crow A.R., Grossbard E., Bussel J.B. Of mice and men: an open-label pilot study for treatment of immune thrombocytopenic purpura by an inhibitor of Syk. Blood 2009, 113:3154-3160.
6. Yamagishi S.I., Edelstein D., Du X.L., Brownlee M. Hyperglycemia potentiates collagen-induced platelet activation through mitochondrial superoxide overproduction. Diabetes 2001, 50:1491-1494.
7. Yang W.S., Seo J.W., Han N.J., Choi J., Lee K.U., Ahn H., Lee S.K., Park S.K. High glucose-induced NF-κB activation occurs via tyrosine phosphorylation of IκBα in human glomerular endothelial cells: involvement of Syk tyrosine kinase. Am. J. Physiol. Renal Physiol. 2008, 294:F1065-F1075.
8. Wada T., Yokoyama H., Matsushima K., Kobayashi K. Monocyte chemoattractant protein-1: does it play a role in diabetic nephropathy?. Nephrol. Dial. Transplant 2003, 18:457-459.
9. Yung S., Lee C.Y., Zhang Q., Lau S.K., Tsang R.C., Chan T.M. Elevated glucose induction of thrombospondin-1 up-regulates fibronectin synthesis in proximal renal tubular epithelial cells through TGF-Β1 dependent and TGF-Β1 independent pathways. Nephrol. Dial. Transplant 2006, 21:1504-1513.
10. Weigert C., Sauer U., Brodbeck K., Pfeiffer A., Häring H.U., Schleicher E.D. AP-1 proteins mediate hyperglycemia-induced activation of the human TGF-Β1 promoter in mesangial cells. J. Am. Soc. Nephrol. 2000, 11:2007-2016.
11. Wu D., Peng F., Zhang B., Ingram A.J., Kelly D.J., Gilbert R.E., Gao B., Krepinsky J.C. PKC-Β1 mediates glucose-induced Akt activation and TGF-Β1 upregulation in mesangial cells. J. Am. Soc. Nephrol. 2009, 20:554-566.
12. Isono M., Cruz M.C., Chen S., Hong S.W., Ziyadeh F.N. Extracellular signal-regulated kinase mediates stimulation of TGF-Β1 and matrix by high glucose in mesangial cells. J. Am. Soc. Nephrol. 2000, 11:2222-2230.
13. Fujita H., Omori S., Ishikura K., Hida M., Awazu M. MERK and p38 mediate high-glucose-induced hypertrophy and TGF-Β expression in renal tubular cells. Am. J. Physiol. Renal Physiol. 2004, 286:F120-F126.
14. Lee K.Y., Ito K., Hayashi R., Jazrawi E.P., Barnes P.J., Adcock I.M. NF-κB and activator protein 1 response elements and the role of histone modifications in IL-1Β-induced TGF-Β1 gene transcription. J. Immunol. 2006, 176:603-615.
15. Miah S.M., Sada K., Tuazon P.T., Ling J., Maeno K., Kyo S., Qu X., Tohyama Y., Traugh J.A., Yamamura H. Activation of Syk protein tyrosine kinase in response to osmotic stress requires interaction with p21-activated protein kinase Pak2/γ -PAK. Mol. Cell. Biol. 2004, 24:71-83.
16. Yang W.S., Lee J.M., Han N.J., Kim Y.J., Chang J.W., Park S.K. Mycophenolic acid attenuates tumor necrosis factor-α-induced endothelin-1 production in human aortic endothelial cells. Atherosclerosis 2010, 211:48-54.
17. Zhang J., Billingsley M.L., Kincaid R.L., Siraganian R.P. Phosphorylation of Syk activation loop tyrosines is essential for Syk function. An in vivo study using a specific anti-Syk activation loop phosphotyrosine antibody. J. Biol. Chem. 2000, 275:35442-35447.
18. Garg A., Aggarwal B.B. Nuclear transcription factor-κB as a target for cancer drug development. Leukemia 2002, 16:1053-1068.
19. Hoffman B.B., Sharma K., Zhu Y., Ziyadeh F.N. Transcriptional activation of transforming growth factor-Β1 in mesangial cell culture by high glucose concentration. Kidney Int. 1998, 54:1107-1116.
20. Rameshwar P., Narayanan R., Qian J., Denny T.N., Colon C., Gascon P. NF-κB as a central mediator in the induction of TGF-Β in monocytes from patients with idiopathic myelofibrosis: an inflammatory response beyond the realm of homeostasis. J. Immunol. 2000, 165:2271-2277.
21. Komura E., Tonetti C., Penard-Lacronique V., Chagraoui H., Lacout C., Lecouédic J.P., Rameau P., Debili N., Vainchenker W., Giraudier S. Role for the nuclear factor κB pathway in transforming growth factor-Β1 production in idiopathic myelofibrosis: possible relationship with FK506 binding protein 51 overexpression. Cancer Res. 2005, 65:3281-3289.
22. Lin W., Tsai W.L., Shao R.X., Wu G., Peng L.F., Barlow L.L., Chung W.J., Zhang L., Zhao H., Jang J.Y., Chung R.T. Hepatitis C virus regulates transforming growth factor Β1 production through the generation of reactive oxygen species in a nuclear factor κB-dependent manner. Gastroenterology 2010, 138:2509-2518.
23. Perez J.R., Higgins-Sochaski K.A., Maltese J.Y., Narayanan R. Regulation of adhesion and growth of fibrosarcoma cells by NF-κB RelA involves transforming growth factor Β. Mol. Cell. Biol. 1994, 14:5326-5332.
24. Whitmarsh A.J., Davis R.J. Transcription factor AP-1 regulation by mitogen-activated protein kinase signal transduction pathways. J. Mol. Med. (Berl.) 1996, 589-607.
25. Monje P., Hernández-Losa J., Lyons R.J., Castellone M.D., Gutkind J.S. Regulation of the transcriptional activity of c-Fos by ERK. A novel role for the prolyl isomerase PIN1. J. Biol. Chem. 2005, 280:35081-35084.
26. DiDonato J.A., Hayakawa M., Rothwarf D.M., Zandi E., Karin M. A cytokine-responsive IκB kinase that activates the transcription factor NF-κB. Nature 1997, 388:548-554.
27. Regnier C.H., Song H.Y., Gao X., Goeddel D.V., Cao Z., Rothe M. Identification and characterization of an IκB kinase. Cell 1997, 90:373-383.
28. Bui N.T., Livolsi A., Peyron J.F., Prehn J.H. Activation of nuclear factor κB and bcl-x survival gene expression by nerve growth factor requires tyrosine phosphorylation of IκBα. J. Cell Biol. 2001, 152:753-764.
29. Imbert V., Rupec R.A., Livolsi A., Pahl H.L., Traenckner E.B., Mueller-Dieckmann C., Farahifar D., Rossi B., Auberger P., Baeuerle P.A., Peyron J.F. Tyrosine phosphorylation of IκB-α activates NF-κB without proteolytic degradation of IκB-α. Cell 1996, 86:787-798.
30. Mercurio F., Zhu H., Murray B.W., Shevchenko A., Bennet B.L., Li J., Young D., Barbosa M., Mann M., Manning A.M., Rao A. IKK-1 and IKK-2: cytokine-activated IκB kinase essential for NF-κB activation. Science 1997, 278:860-866.
31. Ramana K.V., Friedrich B., Bhatnagar A., Srivastava S.K. Aldose reductase mediates cytotoxic signals of hyperglycemia and TNF-α in human lens epithelial cells. FASEB J. 2003, 17:315-317.
32. Ramana K.V., Friedrich B., Srivastava S., Bhatnagar A., Srivastava S.K. Activation of nuclear factor-κB by hyperglycemia in vascular smooth muscle cells is regulated by aldose reductase. Diabetes 2004, 53:2910-2920.
33. Takada Y., Mukhopadhyay A., Kundu G.C., Mahabeleshwar G.H., Singh S., Aggarwal B.B. Hydrogen peroxide activates NF-κB through tyrosine phosphorylation of IκBα and serine phosphorylation of p65: evidence for the involvement of IκBα kinase and Syk protein-tyrosine kinase. J. Biol. Chem. 2003, 278:24233-24241.
34. Qin S., Ding J., Takano T., Yamamura H. Involvement of receptor aggregation and reactive oxygen species in osmotic stress-induced Syk activation in B cells. Biochem. Biophys. Res. Commun. 1999, 262:231-236.
35. Alicic R.Z., Tuttle K.R. Management of the diabetic patient with advanced chronic kidney disease. Semin. Dial. 2010, 23:140-147.